INTERNATIONAL PATENT: DANA-FARBER CANCER INSTITUTE, INC. FILES APPLICATION FOR "RECEPTOR-MEDIATED ENDOCYTOSIS FOR IMPROVED TARGETED INTERNALIZATION AND DEGRADATION OF MEMBRANE PROTEINS AND CARGOS"

GENEVA, Sept. 22 -- DANA-FARBER CANCER INSTITUTE, INC. (450 Brookline AvenueBoston, Massachusetts 02215) filed a patent application (PCT/US2025/020277) for "RECEPTOR-MEDIATED ENDOCYTOSIS FOR IMPROVED TARGETED INTERNALIZATION AND DEGRADATION OF MEMBRANE PROTEINS AND CARGOS" on Mar 17, 2025. With publication no. WO/2025/194172, the details related to the patent application was published on Sep 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZHOU, Xin (450 Brookline AvenueBoston, Massachusetts 02215), RHEE, Kaitlin (450 Brookline AvenueBoston, Massachusetts 02215)

Abstract: Disclosed are...